T cell apoptosis and inflammatory bowel disease

Gut

Volumn 53, Issue 11, 2004, Pages 1556-1558

  Peppelenbosch, M P ^a   Van Deventer, S J H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL COMPARTMENTALIZATION; CELL DEATH; CROHN DISEASE; ENTERITIS; ENZYME ACTIVATION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LAMINA PROPRIA; MUCOSAL IMMUNITY; NOTE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS;

APOPTOSIS; COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; T-LYMPHOCYTES;

EID: 7244260258     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.040824     Document Type: Note

References (17)

1. Doering J, Begue B, Lentze MJ, et al. Induction of T lymphocyte apoptosis by sulphasalazine in patients wild Crohn's disease. Gut 2004;53:1632-8.
2. Sturm A, Leite AZ, Danese S, et al. Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis. Gut 2004;53:1624-31.
3. Ina K, Itoh J, Fukushima K, et al. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 1999;163:1081-90.
4. Boirivant M, Marini M, Di Felice G, et al. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 1999;116:557-65.
5. Itoh J, de La Motte C, Strong SA, et al. Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut 2001;49:35-41.
6. Atreya R, Mudter J, Finotto S, et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med 2000;6:583-8.
7. Festjens N, van Gurp M, van Loo G, et al. Bcl-2 family members as sentinels of cellular integrity and role of mitochondrial intermembrane space proteins in apoptotic cell death. Acta Haematol 2004;111:7-27.
8. Van den Brande JM, Braat H, van den Brink GR, et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 2003;124:1774-85.
9. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997;337:1029-35.
10. ten Hove T, van Montfrans C, Peppelenbosch MP, et al. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut 2002;50:206-11.
11. Sandborn WJ, Hanauer SB, Katz S, et al. Etanercept far active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2001;121:1088-94.
12. Tiede I, Fritz G, Strand S, et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+T lymphocytes. J Clin Invest 2003;111:1133-45.
13. Ponchel F, Morgan AW, Bingham SJ, et al. Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis. Blood 2002;100:4550-6.
14. Henriksson G, Brant M, Sallmyr A, et al. Enhanced DNA damage-induced p53 peptide phosphorylation and cell-cycle arrest in Sjogren's syndrome cells. Eur J Clin Invest 2002;32:458-65.
15. Lawson BR, Baccala R, Song J, et al. Deficiency of the cyclin kinase inhibitor p21 (WAF-1/CIP-1) promotes apoptosis of activated/memory T cells and inhibits spontaneous systemic autoimmunity. J Exp Med 2004;199:547-57.
16. Hildeman DA, Zhu Y, Mitchell TC, et al. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 2002;16:759-67.
17. Davey GM, Kurts C, Miller JF, et al. Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J Exp Med 2002;196:947-55.